Oranee Tangphao-Daniels, MD

Ms. Oranee Tangphao-Daniels joined Lotus’ Board of Directors on June 30th, 2022. Ms. Oranee has more than 30 years in the pharma industry. She worked for Eli Lilly as a Clinical Pharmacologist/Clinical Research Physician and Amgen as Director to Executive Director. She is now the Chief Medical Officer at Antiva Biosciences, a novel topical therapies development company focusing on pre-cancerous lesions caused by HPV.

Ms. Oranee holds a Master’s degree in Cardiovascular Pharmacology from Mc Master University and graduated from Chulalongkorn University with a Bachelor of Medicine (Internal Medicine). She was a Post-Dec then Research Associate at Standford University from 1994 to 2000.